Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | #106 - 1169 Mt. Seymour Road NORTH VANCOUVER BC V7H 2Y4 |
Tel: | N/A |
Website: | https://globalhempgroup.com |
IR: | See website |
Key People | ||
N/A |
Business Overview |
Global Hemp Group Inc. is a Canada-based company, which is focused on developing and promoting hemp-based products. The Company operates through two segments: BioPharma Division and Industrial Hemp Division. BioPharma Division has executed a Letter of Intent (LOI) with B-Organic R&D Corp. (B-Organic) to license its Bioactive Lipid Agents (BLA) technology, a patented matrix, which is able to increase the solubility and bioavailability of various poorly soluble pharma ingredients, including cannabinoids. Industrial Hemp Division is involved in the development and promotion of hemp-based products. The Company's has acquired the perpetual license for North America (the United States, Canada and Mexico) to certain Apollon Intellectual Property and proprietary technology. |
Financial Overview |
For the nine months ended 30 June 2023, Global Hemp Group Inc revenues was not reported. Net loss increased from C$54K to C$282K. Higher net loss reflects FV/Uls Adjust on Derivatives for Hedging decrease of 53% to C$230K (income), Interest and bank charges increase of 39% to C$391K (expense), Government Loan Forgiveness decrease from C$79K (income) to C$0K. Basic Earnings per Share excluding Extraordinary Items totaled to -C$0.02. |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $3.98M as of Sep 30, 2023 |
Annual revenue (TTM): | $0.00M as of Sep 30, 2023 |
EBITDA (TTM): | -$1.38M as of Sep 30, 2023 |
Net annual income (TTM): | -$2.39M as of Sep 30, 2023 |
Free cash flow (TTM): | -$0.10M as of Sep 30, 2023 |
Net Debt Last Fiscal Year: | $3.48M as of Sep 30, 2023 |
Shares outstanding: | 24,291,458 as of Feb 1, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |